As 2024 draws to a close, we’re celebrating a wonderful year of content. From insightful expert Q&As and peer-reviewed articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the cardiology community with high-quality, easily accessible content.

Tricuspid regurgitation (TR) is a frequent finding on echocardiography, with detection rates reaching up to 86% across the different ranges of severity, with moderate or greater TR being reported in at least 6–8% of patients.1–3 The prevalence of TR increases with age, ...

Welcome to the summer issue of Heart International. We are excited to present a collection of insightful articles that delve into various aspects of cardiovascular health and related interventions. This issue encompasses a wide array of topics, from novel treatment ...

Clinically relevant tricuspid regurgitation (TR) is a common disorder, affecting approximately 4% of people 75 years of age or older.1 If left untreated, severe TR results in volume overload and right ventricular remodelling. This eventually leads to symptomatic right-sided heart failure, along ...

The bRIGHT study aimed to evaluate the safety and effectiveness of the TriClip device in symptomatic patients with severe tricuspid regurgitation. In this touchCARDIO interview, we speak with Professor Erwan Donal (University Hospital of Rennes, Rennes, France) to discuss tricuspid ...

Tricuspid regurgitation (TR) is a complex disease with several independent causes. Consequently, outcomes and response to therapy vary widely. Severe or progressive TR often results in gradual right ventricular (RV) failure and is associated with poor long-term outcomes.1 Most cases ...

The left atrial appendage (LAA) is now recognised as a key site of thromboembolic origin in atrial fibrillation (AF), acting as the primary source of around 90% of embolic strokes in non-valvular AF patients.1–4 An important therapeutic strategy for stroke prevention ...